Related Experiment Video
Updated: May 12, 2026

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
Published on: August 10, 2017
Discovery of adamantane based highly potent HDAC inhibitors
Balasubramanian Gopalan1, Thanasekaran Ponpandian, Virendra Kachhadia
1Drug Discovery Research Centre, Orchid Chemicals & Pharmaceuticals Ltd, Chennai 600119, India.
Abstract:
Herein, we report the development of highly potent HDAC inhibitors for the treatment of cancer. A series of adamantane and nor-adamantane based HDAC inhibitors were designed, synthesized and screened for the inhibitory activity of HDAC. A number of compounds exhibited GI50 of 10-100 nM in human HCT116, NCI-H460 and U251 cancer cells, in vitro. Compound 32 displays efficacy in human tumour animal xenograft model.
Related Concept Videos
Inhibition of CDK Activity
Inhibition of Cdk Activity
Drug Discovery: Overview

